Literature DB >> 20638242

Immunosuppressive therapy exacerbates autoimmunity in NOD mice and diminishes the protective activity of regulatory T cells.

Ayelet Kaminitz1, Keren Mizrahi, Isaac Yaniv, Jerry Stein, Nadir Askenasy.   

Abstract

Mounting evidence indicates that immunosuppressive therapy and autologous bone marrow transplantation are relatively inefficient approaches to treat autoimmune diabetes. In this study we assessed the impact of immunosuppression on inflammatory insulitis in NOD mice, and the effect of radiation on immunomodulation mediated by adoptive transfer of various cell subsets. Sublethal radiation of NOD females at the age of 14 weeks (onset of hyperglycemia) delayed the onset of hyperglycemia, however two thirds of the mice became diabetic. Adoptive transfer of splenocytes into irradiated NON and NOD mice precipitated disease onset despite increased contents of CD25(+)FoxP3(+) T cells in the pancreas and regional lymphatics. Similar phenotypic changes were observed when CD25(+) T cells were infused after radiation, which also delayed disease onset without affecting its incidence. Importantly, irradiation increased the susceptibility to diabetes in NOD and NON mice (71-84%) as compared to immunomodulation with splenocytes and CD25(+) T cells in naïve recipients (44-50%). Although irradiation had significant and durable influence on pancreatic infiltrates and the fractions of functional CD25(+)FoxP3(+) Treg cells were elevated by adoptive cell transfer, this approach conferred no protection from disease progression. Irradiation was ineffective both in debulking of pathogenic clones and in restoring immune homeostasis, and the consequent homeostatic expansion evolves as an unfavorable factor in attempts to restore self-tolerance and might even provoke uncontrolled proliferation of pathogenic clones. The obstacles imposed by immunosuppression on abrogation of autoimmune insulitis require replacement of non-specific immunosuppressive therapy by selective immunomodulation that does not cause lymphopenia. Copyright (c) 2010 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20638242     DOI: 10.1016/j.jaut.2010.06.002

Source DB:  PubMed          Journal:  J Autoimmun        ISSN: 0896-8411            Impact factor:   7.094


  10 in total

1.  Stable activity of diabetogenic cells with age in NOD mice: dynamics of reconstitution and adoptive diabetes transfer in immunocompromised mice.

Authors:  Ayelet Kaminitz; Keren Mizrahi; Shifra Ash; Avi Ben-Nun; Nadir Askenasy
Journal:  Immunology       Date:  2014-07       Impact factor: 7.397

2.  Gut immune deficits in LEW.1AR1-iddm rats partially overcome by feeding a diabetes-protective diet.

Authors:  Jennifer A Crookshank; Christopher Patrick; Gen-Sheng Wang; J Ariana Noel; Fraser W Scott
Journal:  Immunology       Date:  2015-03-29       Impact factor: 7.397

3.  Development of diabetic nephropathy in nude mice.

Authors:  S Lin; P C Xu; Q E Huang; J Y Jia; Z H Jia; L Wei; Z F Zheng; W Y Shang
Journal:  J Endocrinol Invest       Date:  2013-05-10       Impact factor: 4.256

Review 4.  Lymphopenia is detrimental to therapeutic approaches to type 1 diabetes using regulatory T cells.

Authors:  Shifra Ash; Shai Yarkoni; Nadir Askenasy
Journal:  Immunol Res       Date:  2014-01       Impact factor: 2.829

5.  Effector and naturally occurring regulatory T cells display no abnormalities in activation induced cell death in NOD mice.

Authors:  Ayelet Kaminitz; Esma S Yolcu; Enosh M Askenasy; Jerry Stein; Isaac Yaniv; Haval Shirwan; Nadir Askenasy
Journal:  PLoS One       Date:  2011-06-27       Impact factor: 3.240

6.  Apoptosis of purified CD4+ T cell subsets is dominated by cytokine deprivation and absence of other cells in new onset diabetic NOD mice.

Authors:  Ayelet Kaminitz; Enosh M Askenasy; Isaac Yaniv; Jerry Stein; Nadir Askenasy
Journal:  PLoS One       Date:  2010-12-31       Impact factor: 3.240

7.  Molecular phenotyping of immune cells from young NOD mice reveals abnormal metabolic pathways in the early induction phase of autoimmune diabetes.

Authors:  Jian Wu; Dorothy N Kakoola; Nataliya I Lenchik; Dominic M Desiderio; Dana R Marshall; Ivan C Gerling
Journal:  PLoS One       Date:  2012-10-11       Impact factor: 3.240

Review 8.  The treatment strategies of autoimmune disease may need a different approach from conventional protocol: a review.

Authors:  S Chandrashekara
Journal:  Indian J Pharmacol       Date:  2012 Nov-Dec       Impact factor: 1.200

Review 9.  Homeostatic T cell proliferation after islet transplantation.

Authors:  Paolo Monti; Lorenzo Piemonti
Journal:  Clin Dev Immunol       Date:  2013-07-22

10.  Molecular pathway alterations in CD4 T-cells of nonobese diabetic (NOD) mice in the preinsulitis phase of autoimmune diabetes.

Authors:  Dorothy N Kakoola; Anita Curcio-Brint; Nataliya I Lenchik; Ivan C Gerling
Journal:  Results Immunol       Date:  2014-05-21
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.